Results : A significantly lower proportion of methylprcdnisolone recipients than untreated participants developed OHSS (20% vs. 43%). Treatment recipients had more oocytcs retrieved and moc embryos fertilized than did untreated participants. Conclusions : Given the corticostcroid (methylprcdnisolone) is a well established and safe medication. This study provides evidence that the use of methylprcdnisolone in the prevention of OHSS in women undergoing assisted reproduction, is successful and without affection of the pregnancy rate.
INTRODUCTION
b) The control group was also initially composed of 32 women receiving a placebo tablet from the day of egg collection till the day of pregnancy test in addition to the luteal support previously mentioned in the study group.
All high-risk patients were seen 5 days after BT to determine whether they had developed clinical 
RESULTS
The age and duration of infertility in both high-risk groups (Table II) 
